Table 7. Stratified analyses between PD-1 rs7421861 A>G polymorphism and EGJA risk by sex, age, smoking status and alcohol consumption.
Variable | PD-1 rs7421861 A>G (case/control)a | Adjusted OR b (95% CI); P | ||||||
---|---|---|---|---|---|---|---|---|
AA | AG | GG | AA | AG | GG | AG/GG | GG vs. (AG/AA) | |
Sex | ||||||||
Male | 455/819 | 262/331 | 29/41 | 1.00 | 1.40 (1.15–1.70); P: 0.001 | 1.20 (0.74–1.97); P: 0.462 | 1.41 (1.16–1.71); P: 0.001 | 1.10 (0.67–1.79); P: 0.712 |
Female | 187/347 | 96/123 | 12/13 | 1.00 | 1.37 (0.99–1.89); P: 0.058 | 1.65 (0.73–3.69); P: 0.228 | 1.46 (1.07–2.00); P: 0.017 | 1.55(0.69–3.46); P: 0.286 |
Age | ||||||||
<64 | 286/590 | 173/212 | 23/21 | 1.00 | 1.62 (1.27–2.08); P: < 0.001 | 2.07 (1.12–3.83); P: 0.021 | 1.73 (1.36–2.20); P: < 0.001 | 1.82 (0.99–3.35); P: 0.054 |
≥64 | 356/576 | 185/242 | 18/33 | 1.00 | 1.21 (0.96–1.53); P: 0.108 | 0.87 (0.48–1.56); P: 0.633 | 1.20 (0.96–1.50); P: 0.113 | 0.83 (0.46–1.49); P: 0.531 |
Smoking status | ||||||||
Never | 465/925 | 263/353 | 26/43 | 1.00 | 1.42 (1.17–1.73); P: < 0.001 | 1.16 (0.70–1.92); P: 0.558 | 1.45 (1.20–1.75); P: < 0.001 | 1.07 (0.65–1.75); P: 0.804 |
Ever | 177/241 | 95/101 | 15/11 | 1.00 | 1.29 (0.91–1.82); P: 0.149 | 1.85 (0.82–4.17); P: 0.139 | 1.36 (0.98–1.90); P: 0.068 | 1.72 (0.77–3.85); P: 0.188 |
Alcohol consumption | ||||||||
Never | 544/1050 | 311/408 | 32/47 | 1.00 | 1.42 (1.19–1.70); P: < 0.001 | 1.26 (0.80–2.00); P: 0.326 | 1.46 (1.22–1.73); P: < 0.001 | 1.15 (0.73–1.82); P: 0.541 |
Ever | 98/116 | 47/46 | 9/7 | 1.00 | 1.14 (0.69–1.89); P: 0.609 | 1.73 (0.59–5.09); P: 0.322 | 1.21 (0.75–1.95); P: 0.441 | 1.66 (0.57–4.83); P: 0.356 |
a The genotyping was successful in 1063 (97.93%) EGJA cases, and 1677 (99.82%) controls for PD-1 rs7421861 A>G;
b Adjusted for age, sex, smoking status and alcohol consumption (besides stratified factors accordingly) in a logistic regression model.